London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Novel ocular fixation and incision device for scleral implant surgery to treat presbyopia

Poster Details

First Author: B.Soloway USA

Co Author(s):    D. Schanzlin              

Abstract Details



Purpose:

To describe a novel device, the Oculock Incision System used with the Refocus Scleral Implant to treat for presbyopia.

Setting:

Private practice clinics in the EU and internationally

Methods:

Refocus Scleral Implants (Refocus Ocular NV) have been used to treat presbyopia since IDE clinical trials began in March 2000 in the USA and continue to be used internationally. Over this time, numerous innovations in the Refocus Scleral Implant device, the surgical instrumentation and the procedure have been made. The Oculock Incision System recently introduced to provide a template guide for Refocus scleral implant placement in EU and international surgery will be described

Results:

The sites in the IDE clinical trial have shown increased improvement in DCNVA with greater stability over time as compared to earlier generations. Pre-operative mean monocular DCNVA in this final cohort was = 20/73. At the two year milestone, 96% of eyes had DCNVA of 20/40 or better OU and an average IOP reduction of 14%. Improved stability was evidenced by the continual improvement seen throughout the course of the study. The Oculock Incision System has improved upon the positioning and reproducibility of the surgery.

Conclusions:

Advancements in implant design, instrumentation and surgical technique have standardized and simplified the Refocus Procedure. The Oculock Incision System is the most recent of these improvements. FINANCIAL INTEREST: One of more of the authors... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, One of more of the authors... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, One of more of the authors... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to Poster listing